Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                Obstetrics, Reproductive and Urologic Drugs Advisory Committee  (formerly Bone, Reproductive and Urologic Drugs Advisory Committee)

Obstetrics, Reproductive and Urologic Drugs Advisory Committee  (formerly Bone, Reproductive and Urologic Drugs Advisory Committee)
              
                        2023 Meeting Materials, Obstetrics, Reproductive and Urologic Drugs Advisory Committee (formerly Bone, Reproductive and Urologic Drugs Advisory Committee)
          2022 Meeting Materials, Obstetrics, Reproductive and Urologic Drugs Advisory Committee (formerly Bone, Reproductive and Urologic Drugs Advisory Committee)
          2019 Meeting Materials, Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))
          Obstetrics, Reproductive and Urologic Drugs Advisory Committee (formerly Bone, Reproductive and Urologic Drugs Advisory Committee) Charter
          Obstetrics, Reproductive and Urologic Drugs Advisory Committee (formerly Bone, Reproductive and Urologic Drugs Advisory Committee) Roster Home
          Advisory Committees
          Committees and Meeting Materials
          Human Drug Advisory Committees
          Obstetrics, Reproductive and Urologic Drugs Advisory Committee  (formerly Bone, Reproductive and Urologic Drugs Advisory Committee)Human Drug Advisory Committees Obstetrics, Reproductive and Urologic Drugs Advisory Committee  (formerly Bone, Reproductive and Urologic Drugs Advisory Committee)
	
	Share
    Post
    Linkedin

    Email
    Print**Meeting materials from 2018 and older are archived.
To view them, please see the**FDA Archive

Purpose

The Committee reviews and evaluates data on the safety and effectiveness of marketed and investigational human drug products for use in the practice of obstetrics, gynecology, urology and related specialties, and makes appropriate recommendations to the Commissioner of Food and Drugs.

Committee Membership

The Committee shall consist of a core of 11 voting members including the Chair.  Members and the Chair are selected by the Commissioner or designee from among authorities knowledgeable in the fields of obstetrics, gynecology, urology, pediatrics, epidemiology, or statistics and related specialties. Members will be invited to serve for overlapping terms of up to four years.  Non-Federal members of this committee will serve as Special Government Employees, representatives or Ex-Officio members.  Federal members will serve as Regular Government Employees or Ex-Officios.  The core of voting members may include one technically qualified member, selected by the Commissioner or designee, who is identified with consumer interests and is recommended by either a consortium of consumer-oriented organizations or other interested persons.  In addition to the voting members, the Committee may include one non-voting representative member who is identified with industry interests.  There may also be an alternate industry representative.

Contact Information

**Joyce Frimpong, PharmD
Designated Federal Officer (DFO)**
Division of Advisory Committee and Consultant Management
Office of Executive Programs
E-mail: ORUDAC@fda.hhs.gov

**FDA Advisory Committee Information Line**
1-800-741-8138
(301) 443-0572 (local number)
Please call the Information Line for up-to-date information on meetings.

Resources For You

Drug Products Committee Vacancies
Contact Information




FDA Advisory Committee Information Line
    1-800-741-8138
    (301-443-0572 in the Washington DC area)**Please call the Information Line for up-to-date information on this meeting.**

                                                                                  Content current as of:
      02/16/2023Obstetrics, Reproductive and Urologic Drugs Advisory Committee  (formerly Bone, Reproductive and Urologic Drugs Advisory Committee)
              
          
                        2023 Meeting Materials, Obstetrics, Reproductive and Urologic Drugs Advisory Committee (formerly Bone, Reproductive and Urologic Drugs Advisory Committee)
          2022 Meeting Materials, Obstetrics, Reproductive and Urologic Drugs Advisory Committee (formerly Bone, Reproductive and Urologic Drugs Advisory Committee)
          2019 Meeting Materials, Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Advisory Committee for Reproductive Health Drugs (ACRHD))
          Obstetrics, Reproductive and Urologic Drugs Advisory Committee (formerly Bone, Reproductive and Urologic Drugs Advisory Committee) Charter
          Obstetrics, Reproductive and Urologic Drugs Advisory Committee (formerly Bone, Reproductive and Urologic Drugs Advisory Committee) Roster
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop